Huntington's disease, formerly known as "St. Vitus' dance," is a rare and incurable brain disorder characterized by movement ...
FITBOOK magazine on MSN
Chorea Huntington: Symptoms of the Rare Brain Disorder
Those affected often remain unaware of their condition for a long time—to outsiders, it may seem as if the person is ...
Researchers announce breakthrough results for AMT-130, the first disease-modifying treatment for Huntington's disease, with ...
Health and Me on MSN
Huntington’s Disease Gets First Successful Treatment: Here’s What To Know About The Condition And Early Symptoms
Huntington’s disease is an uncommon inherited condition that gradually destroys brain cells and currently has no cure. The Genetic and Rare Diseases Information Center (GARD) estimates that fewer than ...
After years of heartbreak, researchers have found an experimental treatment that can slow the progression of Huntington’s ...
SAN DIEGO, Sept. 30, 2024 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NBIX) (Nasdaq: NBIX) today announced interim results from the ongoing open-label KINECT ®-HD2 study of INGREZZA ® (valbenazine) ...
Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today presented new data from the open-label KINECT®-HD2 study demonstrating an established long-term safety profile, tolerability and sustained ...
SAN DIEGO, March 17, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) presented data from the KINECT®-HD study showcasing significant improvements in chorea across body regions with ...
SAN DIEGO, Nov. 2, 2023 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NBIX) (Nasdaq: NBIX) today announced interim results from the ongoing open-label KINECT ®-HD2 study about INGREZZA ® (valbenazine) ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback